Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O
A method for determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer
β Scribed by Anthony V. D'Amico; Richard Whittington; S.Bruce Malkowicz; Delray Schultz
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 556 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostateβspecific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio
## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative longβterm efficacy of radical prostatectomy (RP) versus conventionalβdose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A